Search
alogliptin/pioglitazone (Oseni)
Indications:
- diabetes mellitus type 2
- for use in combination with diet & exercise [1]
Dosage: tablet
Adverse effects:
- rhinorrhea
- sore throat
- back pain
- upper respiratory infection
- black box warning for heart failure due to pioglitazone
Interactions
drug interactions
drug adverse effects of hypoglycemic agents
General
hypoglycemic combination
References
- FDA News Release: Jan. 25, 2013
FDA approves three new drug treatments for type 2 diabetes
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336942.htm
Components
alogliptin (Nesina)
pioglitazone (Actos)